{"id":"https://openalex.org/W7222997367","doi":"https://doi.org/10.3389/fimmu.2026.1980175","title":"SPP1 promotes anoikis resistance and metastatic phenotypes in hepatocellular carcinoma through PI3K-sensitive signaling","display_name":"SPP1 promotes anoikis resistance and metastatic phenotypes in hepatocellular carcinoma through PI3K-sensitive signaling","publication_year":2026,"publication_date":"2026-10-20","ids":{"openalex":"https://openalex.org/W7222997367","doi":"https://doi.org/10.3389/fimmu.2026.1980175"},"language":"en","primary_location":{"id":"doi:10.3389/fimmu.2026.1980175","doi":"https://doi.org/10.3389/fimmu.2026.1980175","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2026.1980175","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1980175/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1980175/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5159135646","display_name":"Xinyue Zhang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I109935558","display_name":"Ningbo University","ror":"https://ror.org/03et85d35","country_code":"CN","type":"education","lineage":["https://openalex.org/I109935558"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xinyue Zhang","raw_affiliation_strings":["Department of Blood Transfusion, The First Affiliated Hospital of Ningbo University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Blood Transfusion, The First Affiliated Hospital of Ningbo University","institution_ids":["https://openalex.org/I109935558"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006331708","display_name":"Honglong Wei","orcid":"https://orcid.org/0000-0003-3974-4640","observed_orcids":["https://orcid.org/0000-0003-3974-4640"]},"institutions":[{"id":"https://openalex.org/I4210153274","display_name":"Shandong Provincial QianFoShan Hospital","ror":"https://ror.org/03wnrsb51","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210153274"]},{"id":"https://openalex.org/I4210163399","display_name":"Shandong First Medical University","ror":"https://ror.org/05jb9pq57","country_code":"CN","type":"education","lineage":["https://openalex.org/I4210163399"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Honglong Wei","raw_affiliation_strings":["Department of Hepatobiliary Surgery, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hepatobiliary Surgery, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital","institution_ids":["https://openalex.org/I4210153274","https://openalex.org/I4210163399"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159135605","display_name":"Reguang Pan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210166261","display_name":"Ningbo First Hospital","ror":"https://ror.org/05pkzpg75","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210166261"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Reguang Pan","raw_affiliation_strings":["Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Ningbo University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Ningbo University","institution_ids":["https://openalex.org/I4210166261"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065145056","display_name":"Qiming Ying","orcid":"https://orcid.org/0000-0002-5468-0502","observed_orcids":["https://orcid.org/0000-0002-5468-0502"]},"institutions":[{"id":"https://openalex.org/I109935558","display_name":"Ningbo University","ror":"https://ror.org/03et85d35","country_code":"CN","type":"education","lineage":["https://openalex.org/I109935558"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Qiming Ying","raw_affiliation_strings":["Department of Blood Transfusion, The First Affiliated Hospital of Ningbo University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Blood Transfusion, The First Affiliated Hospital of Ningbo University","institution_ids":["https://openalex.org/I109935558"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159131905","display_name":"YanJin Dong","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"YanJin Dong","raw_affiliation_strings":["Department of Clinical Laboratory, Jinan Second People\u2019s Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Laboratory, Jinan Second People\u2019s Hospital","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5044552429","display_name":"Mingfeng Xia","orcid":"https://orcid.org/0000-0002-5650-0165","observed_orcids":["https://orcid.org/0000-0002-5650-0165","https://orcid.org/0000-0002-4987-5866"]},"institutions":[{"id":"https://openalex.org/I134738993","display_name":"Shandong University of Traditional Chinese Medicine","ror":"https://ror.org/0523y5c19","country_code":"CN","type":"education","lineage":["https://openalex.org/I134738993"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Mingfeng Xia","raw_affiliation_strings":["Institute of Pharmacy (Institute of Traditional Chinese Medicine (TCM) Health Industrial Technology), Shandong University of Traditional Chinese Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Pharmacy (Institute of Traditional Chinese Medicine (TCM) Health Industrial Technology), Shandong University of Traditional Chinese Medicine","institution_ids":["https://openalex.org/I134738993"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5044552429","https://openalex.org/A5159131905"],"corresponding_institution_ids":["https://openalex.org/I134738993"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.82522841,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"17","issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12110","display_name":"Bone and Dental Protein Studies","score":0.9409000277519226,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12110","display_name":"Bone and Dental Protein Studies","score":0.9409000277519226,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.023499999195337296,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12030","display_name":"S100 Proteins and Annexins","score":0.006300000008195639,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/osteopontin","display_name":"osteopontin","score":0.9950000047683716},{"id":"https://openalex.org/keywords/hepatocellular-carcinoma","display_name":"hepatocellular carcinoma","score":0.9760000109672546},{"id":"https://openalex.org/keywords/anoikis-resistance","display_name":"anoikis resistance","score":1.0},{"id":"https://openalex.org/keywords/metastasis","display_name":"metastasis","score":0.7879999876022339},{"id":"https://openalex.org/keywords/pi3k-signaling","display_name":"PI3K signaling","score":0.890999972820282},{"id":"https://openalex.org/keywords/akt-activation","display_name":"Akt activation","score":0.9269999861717224},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.9599999785423279},{"id":"https://openalex.org/keywords/myeloid-cells","display_name":"myeloid cells","score":0.7910000085830688},{"id":"https://openalex.org/keywords/lung-colonization","display_name":"lung colonization","score":0.5699999928474426},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.7699999809265137},{"id":"https://openalex.org/keywords/alpha-fetoprotein","display_name":"alpha-fetoprotein","score":0.7710000276565552},{"id":"https://openalex.org/keywords/epithelial-mesenchymal-transition","display_name":"epithelial-mesenchymal transition","score":0.8069999814033508},{"id":"https://openalex.org/keywords/extracellular-matrix","display_name":"extracellular matrix","score":0.47200000286102295}],"concepts":[{"id":"https://openalex.org/C152000582","wikidata":"https://www.wikidata.org/wiki/Q567522","display_name":"Anoikis","level":4,"score":0.7986999750137329},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.7526000142097473},{"id":"https://openalex.org/C2777609662","wikidata":"https://www.wikidata.org/wiki/Q416356","display_name":"PTEN","level":4,"score":0.5202000141143799},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.48809999227523804},{"id":"https://openalex.org/C2780804394","wikidata":"https://www.wikidata.org/wiki/Q411994","display_name":"Osteopontin","level":2,"score":0.476500004529953},{"id":"https://openalex.org/C119056186","wikidata":"https://www.wikidata.org/wiki/Q1431332","display_name":"Gene silencing","level":3,"score":0.4706000089645386},{"id":"https://openalex.org/C2780932548","wikidata":"https://www.wikidata.org/wiki/Q1056532","display_name":"CD44","level":3,"score":0.46219998598098755},{"id":"https://openalex.org/C117262875","wikidata":"https://www.wikidata.org/wiki/Q5135057","display_name":"Clonogenic assay","level":3,"score":0.4368000030517578},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.43380001187324524},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4083000123500824},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.3959999978542328},{"id":"https://openalex.org/C97037327","wikidata":"https://www.wikidata.org/wiki/Q5334291","display_name":"Ectopic expression","level":3,"score":0.3926999866962433},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.38670000433921814},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.359499990940094},{"id":"https://openalex.org/C127716648","wikidata":"https://www.wikidata.org/wiki/Q104053","display_name":"Phenotype","level":3,"score":0.33570000529289246},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.328000009059906},{"id":"https://openalex.org/C555283112","wikidata":"https://www.wikidata.org/wiki/Q1637543","display_name":"Carcinogenesis","level":3,"score":0.32120001316070557},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3084000051021576},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.303600013256073},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.3000999987125397},{"id":"https://openalex.org/C137738243","wikidata":"https://www.wikidata.org/wiki/Q189092","display_name":"Cell migration","level":3,"score":0.2897000014781952},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.28769999742507935},{"id":"https://openalex.org/C2779256057","wikidata":"https://www.wikidata.org/wiki/Q16909647","display_name":"Tumor progression","level":3,"score":0.2818000018596649},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.27390000224113464},{"id":"https://openalex.org/C49744831","wikidata":"https://www.wikidata.org/wiki/Q600121","display_name":"Virotherapy","level":4,"score":0.26440000534057617},{"id":"https://openalex.org/C2780210213","wikidata":"https://www.wikidata.org/wiki/Q212961","display_name":"Pancreatic cancer","level":3,"score":0.2623000144958496},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.2614000141620636},{"id":"https://openalex.org/C2781278892","wikidata":"https://www.wikidata.org/wiki/Q18556340","display_name":"Clear cell renal cell carcinoma","level":3,"score":0.25369998812675476}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.3389/fimmu.2026.1980175","doi":"https://doi.org/10.3389/fimmu.2026.1980175","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2026.1980175","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1980175/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},{"id":"pmh:oai:doaj.org/article:a201d90b23574b3d917e5ee0439275ca","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/a201d90b23574b3d917e5ee0439275ca","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Immunology, Vol 17 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fimmu.2026.1980175","doi":"https://doi.org/10.3389/fimmu.2026.1980175","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2026.1980175","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1980175/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320311026","display_name":"Shandong University","ror":"https://ror.org/0207yh398"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7222997367.pdf","grobid_xml":"https://content.openalex.org/works/W7222997367.grobid-xml"},"referenced_works_count":40,"referenced_works":["https://openalex.org/W2001165015","https://openalex.org/W2004398438","https://openalex.org/W2047902687","https://openalex.org/W2077569218","https://openalex.org/W2099540110","https://openalex.org/W2107277218","https://openalex.org/W2119508007","https://openalex.org/W2130410032","https://openalex.org/W2130430382","https://openalex.org/W2134233475","https://openalex.org/W2137022580","https://openalex.org/W2138362890","https://openalex.org/W2144884298","https://openalex.org/W2151334198","https://openalex.org/W2214074259","https://openalex.org/W2310005049","https://openalex.org/W2533508881","https://openalex.org/W2606513998","https://openalex.org/W2625559053","https://openalex.org/W2744377419","https://openalex.org/W2792376809","https://openalex.org/W2885142833","https://openalex.org/W2905296745","https://openalex.org/W2978708928","https://openalex.org/W2982638381","https://openalex.org/W3007935255","https://openalex.org/W3132661792","https://openalex.org/W3213277274","https://openalex.org/W4210774372","https://openalex.org/W4211233744","https://openalex.org/W4311579386","https://openalex.org/W4318197608","https://openalex.org/W4324306066","https://openalex.org/W4367368980","https://openalex.org/W4377011124","https://openalex.org/W4390444515","https://openalex.org/W4393111577","https://openalex.org/W4393935425","https://openalex.org/W4401051481","https://openalex.org/W4401052336"],"related_works":["https://openalex.org/W4401052336","https://openalex.org/W2372551638","https://openalex.org/W7171974540","https://openalex.org/W4321378656","https://openalex.org/W1998933379","https://openalex.org/W3028786420","https://openalex.org/W4200541902","https://openalex.org/W4406983716","https://openalex.org/W1973587429","https://openalex.org/W7155214721"],"abstract_inverted_index":{"Background":[0],"Anoikis":[1],"resistance":[2,53,245,376],"enables":[3],"tumor":[4,95,397],"cells":[5],"detached":[6],"from":[7,340],"the":[8,20,47,59,93,104,267,324,327,330,400,417],"extracellular":[9],"matrix":[10],"to":[11,102,158,246,374,387],"survive":[12],"during":[13],"metastatic":[14,55,301,378],"dissemination,":[15],"yet":[16],"its":[17,421],"relationship":[18],"with":[19,83,173,187,192,298,307,338,412,423],"immune":[21],"microenvironment":[22],"of":[23,49,62,74,92,107,142,269,274],"hepatocellular":[24],"carcinoma":[25],"(HCC)":[26],"remains":[27],"incompletely":[28],"understood.":[29],"Secreted":[30],"phosphoprotein":[31],"1":[32],"(SPP1),":[33],"which":[34],"encodes":[35],"osteopontin":[36],"(OPN),":[37],"has":[38],"been":[39],"implicated":[40],"in":[41,51,65,118,160,170,183,209,229,291,296,364,380,416,428],"HCC":[42,119,174,184,230,292,339,414],"progression.":[43],"This":[44],"study":[45],"investigated":[46],"role":[48],"SPP1":[50,68,108,114,180,194,207,224,235,250,275,372,393],"anoikis":[52,260,375],"and":[54,57,86,109,121,125,135,151,165,175,185,199,212,220,232,244,263,282,293,316,350,361,377,382,420],"phenotypes":[56,379,384],"evaluated":[58],"clinical":[60],"relevance":[61],"circulating":[63],"OPN":[64,164,287,304,409],"HCC.":[66],"Methods":[67],"was":[69,100,116,145,181,226,305,410],"prioritized":[70],"through":[71],"integrated":[72],"analyses":[73,391],"TCGA-LIHC":[75],"data,":[76],"including":[77],"differential":[78],"expression,":[79,265],"survival":[80,310,318],"association,":[81],"intersection":[82],"anoikis-related":[84],"genes,":[85],"pathway":[87],"enrichment,":[88],"followed":[89],"by":[90],"characterization":[91],"associated":[94,186,306,411],"microenvironment.":[96],"Single-cell":[97,203,390],"transcriptomic":[98],"analysis":[99,204],"performed":[101],"determine":[103],"cellular":[105],"distribution":[106],"infer":[110],"potential":[111,214],"intercellular":[112],"communication.":[113],"expression":[115,195,208,225],"validated":[117],"tissues":[120,231],"cell":[122,129,233,238],"lines.":[123,234],"Gain-":[124],"loss-of-function":[126],"experiments":[127],"assessed":[128],"viability,":[130,239],"clonogenic":[131,240],"growth,":[132,241],"migration,":[133,242],"invasion,":[134,243],"apoptosis":[136],"under":[137,329],"poly-HEMA":[138],"suspension.":[139],"The":[140],"involvement":[141,268],"PI3K":[143,388],"signaling":[144],"examined":[146],"using":[147],"LY294002.":[148],"Subcutaneous":[149],"xenograft":[150,280],"experimental":[152,406],"pulmonary":[153,283],"colonization":[154],"models":[155],"were":[156,168,289,294,343],"used":[157],"evaluate":[159],"vivo":[161],"phenotypes.":[162,285],"Serum":[163,286],"alpha-fetoprotein":[166],"(AFP)":[167],"measured":[169],"58":[171],"patients":[172,297,337],"36":[176],"healthy":[177,341],"controls.":[178],"Results":[179],"upregulated":[182],"shorter":[188,308],"overall":[189,309],"survival.":[190],"Tumors":[191],"high":[193],"exhibited":[196],"a":[197,395],"myeloid-":[198],"stroma-enriched":[200],"microenvironmental":[201],"profile.":[202],"identified":[205],"prominent":[206],"myeloid":[210],"populations":[211],"inferred":[213,401],"SPP1-mediated":[215],"communication":[216,402],"between":[217],"macrophage":[218],"subsets":[219],"malignant":[221],"hepatocytes.":[222],"Increased":[223],"independently":[227],"confirmed":[228],"overexpression":[236],"enhanced":[237],"suspension-induced":[247],"apoptosis,":[248],"whereas":[249],"silencing":[251],"produced":[252,276],"reciprocal":[253,277],"effects.":[254],"LY294002":[255],"attenuated":[256],"SPP1-induced":[257],"AKT":[258],"activation,":[259],"resistance,":[261],"motility,":[262],"mesenchymal-marker":[264],"supporting":[266],"PI3K-sensitive":[270],"signaling.":[271],"Bidirectional":[272],"manipulation":[273],"effects":[278],"on":[279],"growth":[281],"colonization-related":[284],"concentrations":[288],"elevated":[290],"higher":[295],"advanced-stage":[299],"or":[300],"disease.":[302],"High":[303],"(HR,":[311,319],"1.93;":[312],"95%":[313,321],"CI,":[314,322],"1.01\u20133.69)":[315],"disease-free":[317],"2.29;":[320],"1.19\u20134.39).In":[323],"same":[325],"cohort,":[326,419],"areas":[328],"receiver":[331],"operating":[332],"characteristic":[333],"curve":[334],"for":[335,345,348,352],"distinguishing":[336],"controls":[342],"0.819":[344],"OPN,":[346],"0.781":[347],"AFP,":[349],"0.879":[351],"their":[353],"combination.":[354],"These":[355],"findings":[356],"represent":[357],"exploratory":[358,426],"same-cohort":[359],"discrimination":[360],"require":[362,404],"validation":[363],"an":[365],"independent,":[366,429],"clinically":[367,430],"representative":[368,431],"at-risk":[369,432],"population.":[370],"Conclusion":[371],"contributes":[373],"HCC,":[381],"these":[383],"are":[385],"sensitive":[386],"inhibition.":[389],"place":[392],"within":[394],"myeloid-associated":[396],"microenvironment,":[398],"while":[399],"signals":[403],"further":[405],"validation.":[407],"Circulating":[408],"aggressive":[413],"features":[415],"present":[418],"combination":[422],"AFP":[424],"warrants":[425],"evaluation":[427],"populations.":[433]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-10-21T00:00:00"}